Cn1c(=O)n(C)c2cc(NC(=O)c3ccccc3[N+](=O)[O-])c(Br)cc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?